<DOC>
	<DOCNO>NCT01286207</DOCNO>
	<brief_summary>This record describe pool data three extension study : MK-0462-022 ( NCT00897949 ) ; MK-0462-025 ( NCT00899379 ) ; MK-0462-029 ( NCT00897104 ) . These study examine long-term safety efficacy rizatriptan use treatment acute migraine migraine recurrence .</brief_summary>
	<brief_title>Long-Term Exposure Rizatriptan 5-mg 10-mg Oral Tablet ( Combined Extension Protocols MK-0462-022 , MK-0462-025 , MK-0462-029 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Participant take part study MK0462022 , MK0462025 , MK0462029 History migraine headache</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Migraine headache</keyword>
</DOC>